Investor's Business Daily on MSN2d
Does AstraZeneca Have 'One Pill To Rule Them All' In Cholesterol?AstraZeneca said Monday its experimental pill lowered "bad" LDL cholesterol by 51%. The results showed promise again rival drugs from Merck and NewAmsterdam Pharma, but AstraZeneca stock fell in line ...
Dosing a statin (rosuvastatin) every other day (EOD) may provide significant lipoprotein changes while avoiding common adverse effects in this statin-intolerant population. Objective: To determine ...
[27] If patients do not reach LDL goals with diet and exercise ... these occur in a minority of the entire population of patients with claudication. Role of Lowering LDL-C in PAD There are ...
HealthDay News — Combination lipid-lowering therapy (LLT) is associated with a greater reduction in low-density lipoprotein cholesterol (LDL-C) compared with statin monotherapy, according to a study ...
Hosted on MSN1mon
Old enough to write CV? Get cholesterol tested tooThe general population and low-risk individuals should maintain LDL-C levels below 100 mg/dL ... of statins and oral non-statin drugs. If goals are not achieved, injectable lipid-lowering drugs ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback